| |
| |
|
| Insider
Information: |
Wentworth Kory James |
| Relationship: |
Chief Financial Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
92,682 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,593 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
92,682 |
|
|
| Total
Value |
$8,593 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -94.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bluebird Bio, Inc. |
BLUE |
|
2020-08-03 |
9,512 |
2018-01-02 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Chief Financial Officer |
2024-03-15 |
83,170 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,006 |
20,541 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-16 |
4 |
OE |
$2.10 |
$210 |
D/D |
100 |
20,641 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-16 |
4 |
AS |
$13.00 |
$2,600 |
D/D |
(200) |
20,441 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-17 |
4 |
AS |
$13.07 |
$2,614 |
D/D |
(200) |
20,341 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-17 |
4 |
OE |
$2.10 |
$210 |
D/D |
100 |
20,541 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-18 |
4 |
OE |
$2.10 |
$210 |
D/D |
100 |
20,441 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-18 |
4 |
AS |
$13.00 |
$2,600 |
D/D |
(200) |
20,221 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-19 |
4 |
AS |
$13.08 |
$111,530 |
D/D |
(8,529) |
16,144 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-19 |
4 |
OE |
$2.10 |
$9,349 |
D/D |
4,452 |
24,673 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-22 |
4 |
AS |
$13.00 |
$2,822 |
D/D |
(217) |
16,044 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-22 |
4 |
OE |
$2.10 |
$246 |
D/D |
117 |
16,261 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-23 |
4 |
AS |
$13.09 |
$38,080 |
D/D |
(2,909) |
14,538 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-23 |
4 |
OE |
$2.10 |
$2,946 |
D/D |
1,403 |
17,447 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-24 |
4 |
AS |
$13.52 |
$42,375 |
D/D |
(3,118) |
12,537 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-24 |
4 |
OE |
$2.10 |
$2,346 |
D/D |
1,117 |
15,655 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-08-25 |
4 |
AS |
$14.18 |
$21,986 |
D/D |
(1,551) |
10,986 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,503 |
16,489 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-11-16 |
4 |
OE |
$2.10 |
$420 |
D/D |
200 |
16,709 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-11-16 |
4 |
AS |
$18.10 |
$3,620 |
D/D |
(200) |
16,509 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-12-02 |
4 |
OE |
$2.10 |
$6,111 |
D/D |
2,910 |
19,419 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-12-02 |
4 |
AS |
$18.20 |
$52,949 |
D/D |
(2,910) |
16,509 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-12-05 |
4 |
AS |
$18.05 |
$3,610 |
D/D |
(200) |
16,509 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-12-05 |
4 |
OE |
$2.10 |
$420 |
D/D |
200 |
16,709 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-12-08 |
4 |
AS |
$18.95 |
$86,238 |
D/D |
(4,550) |
16,509 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2022-12-08 |
4 |
OE |
$2.10 |
$9,555 |
D/D |
4,550 |
21,059 |
0 |
- |
|
65 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
